Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SENORES PHARMACEUTICALS LTD.

NSE : SENORESBSE : 544319ISIN CODE : INE0RB801010Industry : Pharmaceuticals & DrugsHouse : Private
BSE815.5531 (+3.95 %)
PREV CLOSE () 784.55
OPEN PRICE () 772.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 50640
TODAY'S LOW / HIGH ()772.55 847.90
52 WK LOW / HIGH ()440 847.9
NSE815.2529.15 (+3.71 %)
PREV CLOSE() 786.10
OPEN PRICE () 783.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 815.25 (29)
VOLUME 1456979
TODAY'S LOW / HIGH() 783.00 848.50
52 WK LOW / HIGH ()435.25 848.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2017

Management Info :

Sanjay Shaileshbhai Majmudar - Chairman Swapnil Jatinbhai Shah - Managing Director

Registered Office :

Address : 1101 To 1103, 11th Floor, South Tower,One 42 Opp. Jayantilal Park,Ambali Bopal Road,
Ahmedabad,
Gujarat-380054

Phone : 079-29999857

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
05Dec Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed that the exchange has received Disc..
05Dec Senores Pharmaceuticals gets marketing
Senores Pharmaceuticals has received marketing authorizations from the P..
07Nov Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed that pursuant to Regulation 30 and..
08Oct Senores Pharmaceuticals informs about
Senores Pharmaceuticals has enclosed a certificate, pursuant to Regulati..
13Aug Senores Pharmaceuticals signs agreemen
Senores Pharmaceuticals through its wholly-owned subsidiary -- Senores P..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit64.336.9
Gross Profit 76.6 51.1
Operating Profit 128.9147.1
Net Sales 353.3385.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Neuland Laboratories (BSE)
 16421.90 (2.15%)
M.Cap ( in Cr)
21069.12
Procter&Gamble Healt (BSE)
 5675.85 (1.74%)
M.Cap ( in Cr)
9421.56
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2372.25 (2.78%)
M.Cap ( in Cr)
3923.47
Shareholding Pattern
PROMOTERS 45.8%
NON-INSTITUTION 41.31%
MUTUAL FUNDS/UTI 3.54%
FI/BANKS/INSURANCE 2.95%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48416.56-41.49 (-0.09%)
Nasdaq 23057.41-137.76 (-0.59%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI